Blinding¶

Why It Matters¶

Expectation effects are powerful and pervasive. Subjects who know they're receiving treatment report better outcomes (placebo effect). Experimenters who know which group is treatment unconsciously measure more carefully, interact more positively, or code ambiguous data favorably (observer bias). These aren't character flaws - they're automatic cognitive processes. Blinding mechanically prevents expectation from contaminating the signal.

The Key Move¶

For any experiment where knowledge of condition could plausibly affect the outcome, blind the relevant parties. If you're testing subjective outcomes (pain, satisfaction, quality), blind subjects. If measurement involves judgment, blind experimenters. Ask: "Could knowing the condition change behavior or measurement?" If yes, blind. If you can't blind (e.g., obvious interventions like surgery), acknowledge the limitation explicitly.

Classic Application¶

Drug trials with inactive placebos. Make the placebo pill look, taste, and feel identical to the drug. Neither patient nor prescribing doctor knows who gets what until after data collection. This isolates the pharmacological effect from the psychological effect of believing you're being treated.

Surprising Application¶

Evaluating your own work. When reviewing multiple solution attempts or design iterations, strip identifying information and randomize the order. Your judgment of "is this good?" is contaminated if you know "I made this on Monday when I was fresh" versus "Friday when I was tired." Blind review reveals which solutions actually work rather than which stories you've told yourself about them.

Failure Modes¶

Incomplete blinding (e.g., drug causes distinctive side effects that reveal assignment). Functional unblinding during the study (experimenters guess correctly who's in which group). Blinding parties who don't need to be blinded while missing parties who do. Over-blinding when it creates practical or ethical problems (e.g., emergency medical situations).

Go Deeper¶

Schulz & Grimes (2002), "Blinding in randomised trials: hiding who got what," Lancet 359(9307); Hróbjartsson et al. (2014), "Observer bias in randomized clinical trials with time-to-event outcomes," JAMA 311(8).